Cohen Lawrence B Has $660,000 Stock Position in Xilinx, Inc. (NASDAQ:XLNX)

Share on StockTwits

Cohen Lawrence B lowered its stake in Xilinx, Inc. (NASDAQ:XLNX) by 11.2% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,596 shares of the programmable devices maker’s stock after selling 705 shares during the quarter. Cohen Lawrence B’s holdings in Xilinx were worth $660,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of XLNX. Dimensional Fund Advisors LP raised its stake in Xilinx by 2.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,002,227 shares of the programmable devices maker’s stock valued at $85,360,000 after acquiring an additional 28,286 shares in the last quarter. Geode Capital Management LLC raised its stake in Xilinx by 13.2% during the 4th quarter. Geode Capital Management LLC now owns 3,888,197 shares of the programmable devices maker’s stock valued at $330,672,000 after acquiring an additional 453,619 shares in the last quarter. Mercer Global Advisors Inc. ADV bought a new stake in Xilinx during the 1st quarter valued at $375,000. Louisiana State Employees Retirement System raised its stake in Xilinx by 0.8% during the 1st quarter. Louisiana State Employees Retirement System now owns 13,400 shares of the programmable devices maker’s stock valued at $1,699,000 after acquiring an additional 100 shares in the last quarter. Finally, Raymond James Trust N.A. bought a new stake in Xilinx during the 1st quarter valued at $447,000. 85.81% of the stock is currently owned by institutional investors and hedge funds.

Several brokerages have weighed in on XLNX. Mizuho lifted their target price on Xilinx from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Thursday, July 25th. ValuEngine downgraded Xilinx from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 13th. Benchmark began coverage on Xilinx in a research report on Tuesday, July 23rd. They set a “hold” rating on the stock. Zacks Investment Research raised Xilinx from a “sell” rating to a “hold” rating and set a $130.00 target price on the stock in a research report on Saturday, July 27th. Finally, Robert W. Baird set a $128.00 target price on Xilinx and gave the stock a “buy” rating in a research report on Friday, July 26th. Fourteen investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $119.52.

In other news, SVP Emre Onder sold 344 shares of the company’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $104.92, for a total value of $36,092.48. Following the sale, the senior vice president now directly owns 1,419 shares in the company, valued at approximately $148,881.48. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Salil Raje sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $120.78, for a total value of $603,900.00. Following the completion of the sale, the executive vice president now owns 24,455 shares in the company, valued at $2,953,674.90. The disclosure for this sale can be found here. Over the last quarter, insiders sold 20,821 shares of company stock worth $2,377,587. Corporate insiders own 0.19% of the company’s stock.

Xilinx stock opened at $106.43 on Wednesday. The firm has a 50 day moving average price of $116.52. The company has a debt-to-equity ratio of 0.48, a quick ratio of 6.54 and a current ratio of 7.22. The firm has a market cap of $26.88 billion, a PE ratio of 30.58, a price-to-earnings-growth ratio of 2.30 and a beta of 1.23. Xilinx, Inc. has a 12 month low of $68.76 and a 12 month high of $141.60.

Xilinx (NASDAQ:XLNX) last released its quarterly earnings data on Wednesday, July 24th. The programmable devices maker reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.03. Xilinx had a return on equity of 35.99% and a net margin of 29.19%. The company had revenue of $849.60 million for the quarter, compared to analyst estimates of $849.76 million. During the same period in the prior year, the company posted $0.74 EPS. The company’s revenue was up 24.1% compared to the same quarter last year. As a group, sell-side analysts expect that Xilinx, Inc. will post 3.77 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 27th. Stockholders of record on Wednesday, August 7th will be paid a $0.37 dividend. The ex-dividend date of this dividend is Tuesday, August 6th. This represents a $1.48 annualized dividend and a dividend yield of 1.39%. Xilinx’s dividend payout ratio is currently 42.53%.

Xilinx Company Profile

Xilinx, Inc designs and develops programmable devices and associated technologies worldwide. Its programmable devices comprise integrated circuits (ICs) in the form of programmable logic devices (PLDs), such as programmable system on chips, and three dimensional ICs; adaptive compute acceleration platform; software design tools to program the PLDs; software development environments and embedded platforms; targeted reference designs; printed circuit boards; and intellectual property (IP) core licenses covering Ethernet, memory controllers, Interlaken, and peripheral component interconnect express interfaces, as well as domain-specific IP in the areas of embedded, digital signal processing and connectivity, and market-specific IP cores.

See Also: Why do earnings reports matter?

Institutional Ownership by Quarter for Xilinx (NASDAQ:XLNX)

Receive News & Ratings for Xilinx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xilinx and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

CorMedix  Raised to “Hold” at Zacks Investment Research
CorMedix Raised to “Hold” at Zacks Investment Research
Artesian Resources Co.  Short Interest Up 10.5% in August
Artesian Resources Co. Short Interest Up 10.5% in August
GN STORE NORD A/ADR  Cut to Hold at Zacks Investment Research
GN STORE NORD A/ADR Cut to Hold at Zacks Investment Research
Gildan Activewear  Upgraded by Zacks Investment Research to “Buy”
Gildan Activewear Upgraded by Zacks Investment Research to “Buy”
Arts-Way Manufacturing Co. Inc.  Short Interest Down 5.3% in August
Arts-Way Manufacturing Co. Inc. Short Interest Down 5.3% in August
GMS  Raised to Buy at Zacks Investment Research
GMS Raised to Buy at Zacks Investment Research


© 2006-2019 Ticker Report